All medical devices sold in Korea must obtain approval from the Korea Food & Drug Administration (KFDA) before they may be sold and marketed in that country. The Medical Devices & Radiation Health Department of KFDA is charged with the inspection and... Read More
With 2000 sales over US$1 billion and demand for medical devices predicted to grow by 10% in 2001, South Korea is Asia’s second largest medical device market, after Japan. Imports from the United States increased nearly 60% in 2000 to US$308 million... Read More
The US Trade Development Agency (TDA) estimates that developing countries in Asia will spend over $6 billion on healthcare technology over the next five years. There are at least 25 large-scale healthcare technology projects either underway or on the drawing board in... Read More
Last summer, the Korean government put into service a new law, the “National Health Insurance Act,” which, among other things, significantly changed Korean government policy regarding reimbursement of medical devices. Government approval of the listed coverage and price is required before a... Read More
Despite sluggish economies in some countries, Asia still represents future growth opportunities in healthcare products. Over the next 20 years, Asian healthcare markets are expected to grow at a rate two and a half times that of the West. A rising standard... Read More
Despite the damage from the Asian financial crisis, South Korea's economy is moving ahead with a surge in imports and increased consumer confidence. The Korean pharmaceutical market is no exception to Korea's economic boom. The Korean Ministry of Health and Welfare (MHW)... Read More
As South Korea's economy rebounds from the Asian financial crisis, its pharmaceutical and medical device markets are also rebounding due to increased demand and consumption. Part of the Korean government's economic reforms include the deregulation of its markets and promoting of foreign... Read More
Despite Asia's short-term economic crisis, Asia will bounce back soon and still be a dominant factor in the 21st century. Similarly, there will be many opportunities for international medical companies in Asia. Before an international medical company can sell its products in... Read More
South Korea's medical market is the third largest in Asia and is worth almost $11 billion. The Asian financial crisis sparked a government reform effort in Korea to liberalize its markets, allowing more foreign investment opportunities, especially in the medical market. The... Read More
Despite its currency crisis, Asia still offers manufacturers many opportunities. Asia's recent currency crisis has caused some U.S. medical device companies to wonder whether there is still a market for their products and services. Concern has risen that Asians have lost their... Read More